Angela Smith-Morgan to step down from her role as Co CEO of Leukaemia UK

After eight successful years with us, Angela Smith-Morgan will be stepping down from her role as Co CEO of Leukaemia UK on 3rd September.

Angela was responsible for driving through the merger with Leuka in November 2019, and is now leaving the charity in a strong position to build on the remarkable transformation she engineered.

She has been a valued Co CEO of the merged charity and a visionary sole CEO of the original charity. We thank her for her outstanding work on our behalf and wish her the very best in the future.

Latest

Pat Walton 1935 - 2022

My Mum, Pat, lived for more than six years with leukaemia, and was fortunate to have her life extended by being prescribed a pioneering antibody drug to help her fight the disease. Without such research, we would likely have lost her much sooner
Run Media City 5K: September 2022

Join team LUK and run a 2.5km loop over the canal and runs past the imperial war museum along with the ITV and BBC television studios.
160ft Bungee: September 2022

This fantastic location is based at the bustling Brighton Marina and is certainly one of our best bungee jumping venues. Get in touch to secure your place, and support Leukaemia UK.
Altrincham 10k

Join team Leukaemia UK and run 10K, supporting our vital work.

First Medical Research Council and Leukaemia UK Clinical Research Training Fellow shares project highlights

Dr Sandeep Potluri's findings will contribute towards a better understanding, cure and treatments of leukaemia and blood cancers
John Goldman Fellowship awarded to Dr Pramila Krishnamurthy

Leukaemia UK is proud to announce Dr Pramila Krishnamurthy of King’s College Hospital and King’s College London as a Leukaemia UK John Goldman Fellow co-funded by Rosetrees Trust. Dr Krishnamurthy will be using the fellowship to better understand why some leukaemia patients relapse following a stem cell transplant, and how donor lymphocyte infusion can help prevent this.
Charities call on NHS to treat blood cancer equally in decision-making

The Blood Cancer Alliance undertook an evidence review to inform a new report exploring the unmet needs of people with blood cancer across the UK.
John Goldman Fellowships for 2022 open in December

Leukaemia UK is delighted to continue its investment and funding for early career scientists and clinicians in 2022.
Dr Samanta Mariani recognised for her innovative research through Leukaemia UK John Goldman Fellowship and Olive Boles Innovation Award

We are delighted to announce the Leukaemia UK John Goldman Fellowship and Olive Boles Innovation Award has been awarded to Dr Samanta Mariani, in recognition of her innovative research that could contribute significantly to our understanding of leukaemia and other blood cancers.
Trustees Week 2021: Why I became a Leukaemia UK Trustee

Caroline Evans - Leukaemia UK Trustee and Projects Consultant - reflects on why she became a Trustee and what drives her in the role.
Leukaemia UK announced as one of five charities for star-studded event Shall We Dance? with Dame Arlene Phillips and Anton Du Beke

Leukaemia UK is delighted to have been announced as one of five charities for whom the proceeds of a new star-studded dance event, Shall We Dance?, will go towards when it takes place next year.
Leukaemia UK drives forward progress for leukaemia research through five new John Goldman Fellowships for 2021

Leukaemia UK announces five new John Goldman Fellows for 2021 to accelerate progress and stop the disease devastating lives.
An urgent call from One Cancer Voice group of cancer charities for the Comprehensive Spending Review to deliver Government commitments to improve cancer survival & care

Leukaemia UK has joined with 50 other cancer charities in writing to the Prime Minister, Chancellor of the Exchequer and Secretary of State for Health and Social Care. We are calling on the Government to urgently deliver on commitments to improve cancer survival and care in the forthcoming Spending Review.
Leading leukaemia charities call on Rishi Sunak not to cut financial lifeline for blood cancer patients

Leukaemia Care, Leukaemia UK and Leukaemia and Lymphoma Northern Ireland, have written to the Chancellor urging him to realise the devastating impact the end of the Coronavirus Job Retention Scheme will have on the clinically extremely vulnerable (CEV).